Company Number: 14037066

Analysis Date: 2025-07-20 18:46 UTC

1. Credit Opinion: DECLINE
   DR V S NAZRAN LTD exhibits significant financial distress as evidenced by negative net assets of £2,788 at the latest year-end. The company’s current liabilities of £335,517 vastly exceed its current assets of £40,866, resulting in a negative net working capital position of £294,651. This poor liquidity position raises serious concerns about the company’s ability to meet short-term obligations or service any additional debt. Given the absence of financial growth or improvement over the last three years, the company appears financially stagnant and undercapitalized. Without stronger equity support or improved cash flows, lending to this entity poses a high credit risk.

2. Financial Strength:
   The balance sheet shows fixed assets of £291,863, which supports some asset backing. However, the company’s liabilities significantly outweigh current assets, leading to a negative working capital and net asset position. Shareholders’ funds are negative, indicating accumulated losses or liabilities exceeding assets. As a micro-entity, the company’s size is small, with only 2 employees, limiting operational scale. The lack of positive equity or retained earnings suggests weak capitalization and limited financial resilience.

3. Cash Flow Assessment:
   Current liabilities exceed current assets by a large margin, implying potential liquidity constraints. The company’s ability to convert fixed assets into cash quickly is limited, given the nature of the assets likely being dental practice-related equipment or property. Without sufficient liquid assets or cash reserves, the company may struggle to cover immediate debts or operational expenses. The absence of reported profitability or cash flow data further clouds the outlook, but the negative working capital is a clear red flag.

4. Monitoring Points:

• Monitor for any improvement in net current assets and liquidity ratios in future accounts.
• Watch for increases in shareholders’ funds or capital injections to strengthen the balance sheet.
• Observe operational profitability and cash flow statements once available to assess debt servicing capability.
• Keep track of any changes in director appointments or significant control that might affect governance or financial strategy.